| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 16, 2023 | May 18, 2023 | Akebia Therapeutics, Inc. | CFO | Sell | 42.5 | -63,567 | -12.46% | ✗ | $67.9K |
| Mar 1, 2023 | Mar 3, 2023 | Akebia Therapeutics, Inc. | CFO | Sell | 47.5 | -7,210 | -1.39% | ✗ | $6.3K |
| Feb 27, 2023 | Mar 1, 2023 | Akebia Therapeutics, Inc. | CFO | Sell | 47.5 | -7,539 | -1.44% | ✗ | $6.1K |
| Feb 28, 2022 | Mar 2, 2022 | Akebia Therapeutics, Inc. | CFO | Sell | 91.3 | +51,797 | 67.44% | ✗ | $17.7K |
| Apr 1, 2021 | Apr 1, 2021 | Akebia Therapeutics, Inc. | CFO | Sell | 47.5 | -790 | -1.02% | ✗ | $2.7K |